# Phacotrabeculectomy With Collagen Matrix Implant (Ologen®) Versus Mitomycin C

> **NCT03506542** · PHASE2 · COMPLETED · sponsor: **Medical University of Lublin** · enrollment: 53 (actual)

## Conditions studied

- Glaucoma
- Cataract
- Wound Heal

## Interventions

- **DEVICE:** Ologen
- **PROCEDURE:** Phacotrabeculectomy
- **DRUG:** Mitomycin C

## Key facts

- **NCT ID:** NCT03506542
- **Lead sponsor:** Medical University of Lublin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-02
- **Primary completion:** 2016-03-01
- **Final completion:** 2017-03-30
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2018-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03506542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03506542, "Phacotrabeculectomy With Collagen Matrix Implant (Ologen®) Versus Mitomycin C". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03506542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*